Clinical Trial Update: A Study to Assess the Absorption, Metabolism and Excretion of Migalastat Hydrochloride (AT1001-014) [Phase 1]

View source ↗

Summary

Phase 1 study update assessing how migalastat hydrochloride is absorbed, metabolized, and excreted in Fabry disease. The trial is sponsored by Amicus Therapeuti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Migalastat hydrochloride (migalastat hydrochloride)

Snippet

Sponsor: Amicus Therapeutics | Conditions: Fabry Disease | Phase 1 | Status: COMPLETED